Cancer Vaccine Institute News

“Finance. Focus. Fortitude. Fearlessness.” These four words have guided a career that has helped shape the future of cancer vaccines. Dr. Nora Disis, CVI Director, Professor of Medicine at the University of Washington and Fred Hutch Cancer Center, Editor-In-Chief of JAMA Oncology and Deputy Editor of JAMA, joins Dr. Robert Camidge to discuss her remarkable career and the future of cancer vaccines. How This Is Building Me is a podcast that focuses on scientists and researchers

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the Cancer Vaccine Institute. Join us in meeting the brilliant minds behind our cancer vaccines and immunotherapies as they share their professional journeys and personal stories. “If you have truly found something that compels you to work really hard, that can carry you in a huge way.” Dr. Brie Chun wears many hats: researcher, physician, climber, and mo

Research from the Cancer Vaccine Institute and others points to a near-term future in which cancer vaccines will play an instrumental role in managing cancer. Therapeutic cancer vaccines are designed to help the immune system recognize and attack cancer cells. A key part of this response is generating T-cells, immune cells, that specifically recognize cancer proteins and create a cancer-killing immune response. Some T-cells become “memory” T-cells, remaining in the body long

The Cancer Vaccine Institute (CVI) is advancing the emerging field of cancer research, developing vaccines to intercept cancer before it becomes invasive. We have developed WOKVAC, a DNA-based vaccine designed to target three proteins - HER2, IGFBP-2, and IGF-1R - highly expressed in most Ductal Carcinoma In Situ (DCIS), a preinvasive form of breast cancer. Although not immediately life-threatening, 20% of DCIS lesions may progress to invasive cancer. Patients diagnosed with